Aldea Pharmaceuticals snags $24 mln Series B
Aldea Pharmaceuticals said Monday that it has received $24 million in Series B financing. The investors included RusnanoMedInvest, WuXi PharmaTech Corporate Ventures, Canaan Partners and Correlation Ventures. Based in Redwood City, Calif., Aldea is focused on developing treatments for aldehyde metabolism disorders.
25 August 2014•2 mins read
